Hemorrhage clinical trials at UCSF

1 research study open to eligible people

Hemorrhage is when someone bleeds a lot. UCSF is doing a study to see if using cold stored platelets can help people with hemorrhagic shock. They are looking for people to join the study. There is also another study happening, but they can't take new people right now.

Showing trials for

  • Cold Stored Platelet in Hemorrhagic Shock

    open to eligible people ages 15-90

    The Cold Stored Platelet Early Intervention in Hemorrhagic Shock (CriSP-HS) trial is a proposed 3 year, open label, multi-center, randomized trial designed to determine the feasibility, efficacy, and safety of urgent release cold stored platelets (CSP) in patients in hemorrhagic shock. Patients will be randomized to receive either standard care or early infusion of urgent release cold stored platelets (CSP). The proposed pilot study will utilize 5 level-1 trauma centers from within the LITES network and will enroll approximately 200 patients. The primary outcome for the pilot trial is feasibility, with principal secondary clinical outcome of 24 hour mortality.

    San Francisco, California and other locations

Our lead scientists for Hemorrhage research studies include .